Skyline Medical promotes chairman Carl Schwartz to CEO
Dr. Schwartz became a director of the Company in March 2016 and was Skyline's interim chief executive officer from May 2016 until his appointment as executive chairman in September 2016. He is a longtime stockholder of Skyline.
Dr. Schwartz has owned and managed dental groups in Michigan, beginning with one practice in 1966 and overseeing an expansion to 14 offices at the time he left the active practice of dentistry in 1988. He currently owns two dental practices in Michigan.
In 1988 Dr. Schwartz joined a family business, becoming chief executive officer of Plastics Research Corporation, a Flint, Mich. manufacturer of structural foam molding, a low pressure injection molding process.
Dr. Schwartz previously served on the board of Delta Dental Corporation of Michigan, and was a member of the Michigan Advisory Board for Liberty Mutual Insurance.
He holds BA and DDS degrees from the University of Detroit.
Richard Gabriel, co-founder and chief operating officer of GLG Pharma, has been appointed to the Company's board of directors.
Mr. Gabriel has more than 40 years of healthcare experience, including two decades of executive leadership and as a director and a consultant to development-stage companies.
In addition serving as chief operating officer of GLG Pharma since 2009, from 2003 until 2009. Mr. Gabriel was chief executive officer of DNAPrint Genomics and DNAPrint Pharmaceuticals.
He is currently a director of Windgap Medical, a Massachusetts-based medical device company that is developing a compact and easy to use epinephrine autoinjector for the treatment of anaphylaxis.
Mr. Gabriel holds an MBA from Suffolk University in Boston, and a BS in Chemistry from Ohio Dominican College in Columbus.